1,152 material Form 8-K filings that 918 companies we cover made with the SEC in October 2025, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Mark C. Birk informed Ameren that he will retire as Chairman and President of Union Electric Company (Ameren Missouri), effective October 2, 2025, and from his other subsidiary roles. Senior Executive Vice President and CFO Michael L. Moehn was elected Interim Chairman and President of Ameren Missouri, a role he previously held from 2014 to 2019. The filing does not describe a permanent successor or any financial effect.
Mark C. Birk to retire as Chairman and President of Ameren Missouri, effective October 2, 2025
Michael L. Moehn, Ameren's CFO since 2019, named Interim Chairman and President of Ameren Missouri
Moehn previously served as Chairman and President of Ameren Missouri from 2014 to 2019
Occidental's Board of Directors promoted Richard A. Jackson, 49, to Chief Operating Officer effective October 1, 2025, while he continues as Senior Vice President. He will oversee global oil and gas operations, low-carbon technologies, midstream and marketing, and health, safety and environment functions, reporting to CEO Vicki Hollub.
Jackson's base salary rises to $925,000 per year, with a 2025 target annual cash incentive of $925,000.
Jackson received restricted stock units valued at $1,500,000, vesting in equal annual installments over three years.
Jackson has been an Occidental employee since 2003 and previously served as President of Operations for U.S. Onshore Resources and Carbon Management.
AIG said director Paola Bergamaschi will leave its board of directors effective October 15, 2025, under a mutual agreement reached on October 1, 2025. Effective October 20, 2025, she will join the board of Talbot Underwriting Ltd., an AIG wholly-owned subsidiary in the Lloyd's Insurance Market. The filing does not give a reason for the board departure and contains no financial results.
Board resignation effective October 15, 2025, mutually agreed on October 1, 2025
Bergamaschi to join Talbot Underwriting Ltd. board effective October 20, 2025
Talbot Underwriting Ltd. is a wholly-owned subsidiary operating in the Lloyd's Insurance Market
DENTSPLY SIRONA said its Executive Vice President, Corporate Development, General Counsel and Secretary, Richard C. Rosenzweig, will leave that role by mutual agreement effective October 3, 2025. He will serve as Special Legal Advisor through March 4, 2026 under a transition agreement that sets severance and consulting terms. The change is an executive transition with defined payments rather than a change in financial results.
Rosenzweig's general counsel and corporate development roles end October 3, 2025; he becomes Special Legal Advisor through March 4, 2026 or earlier termination.
Transition agreement, dated October 2, 2025, provides a $30,000 monthly fixed fee for his Special Legal Advisor services, paid in full if terminated before March 4, 2026 for reasons other than Cause.
After the Separation Date, the company will engage him as an independent contractor consultant for one year at $20,000 per month.
TransDigm Group completed a CEO transition on September 30, 2025, when Michael J. Lisman succeeded Kevin M. Stein as president and chief executive officer. Stein remains on the board and has a consulting agreement to advise the company for up to 24 months at $25,000 per month, with some of his stock options continuing to vest and a portion to be forfeited.
Michael J. Lisman succeeded Kevin M. Stein as President and CEO on September 30, 2025.
Stein, who served nearly 11 years, remains a member of the Board of Directors.
Stein's consulting agreement, dated October 1, 2025, runs for up to 24 months at $25,000 per month.
Stein agreed to forfeit a certain portion of his outstanding stock options granted during his CEO tenure.
Nicolas Kuan Liang Lin resigned as Chief Financial Officer and as a director of Origin Investment Corp I, effective September 29, 2025, and the filing says the resignation was not due to any disagreement with the company. CEO Yung-Hsi ("Edward") Chang will serve as interim CFO until a permanent CFO is identified, so shareholders should watch for that appointment.
Nicolas Kuan Liang Lin resigned as CFO and board member effective September 29, 2025
Filing states the resignation was not due to any disagreement on operations, policies or practices
CEO Yung-Hsi ("Edward") Chang will serve as interim CFO until a permanent CFO is named
On September 30, 2025, Rockwell Automation entered into change of control agreements with Blake D. Moret, Christian E. Rothe, Scott A. Genereux, Tessa M. Myers, Rebecca W. House and certain other officers, replacing agreements that expired on September 30, 2025. The new agreements take effect if a change of control occurs between September 30, 2025 and October 1, 2028, and their terms are described as substantially the same as the expired agreements. The filing is a routine renewal of existing executive protections rather than a change in leadership.
Agreements dated September 30, 2025 replace Change of Control Agreements dated September 30, 2022, which expired by their terms on September 30, 2025.
Agreements take effect on a change of control occurring on or after September 30, 2025 and before October 1, 2028.
Filing includes the Moret agreement (Exhibit 99.1) and the form of agreement for other officers (Exhibit 99.2).
Incyte Corporation's board appointed Thomas Tray, its Vice President, Finance and Chief Accounting Officer, to also serve as principal financial officer, effective September 16, 2025. The filing discloses no compensation terms and no arrangements tied to the appointment, and Mr. Tray has been with the company since June 2005.
Board appointed Thomas Tray as principal financial officer on September 30, 2025, effective September 16, 2025
Tray already serves as Vice President, Finance and Chief Accounting Officer (principal accounting officer)
Tray, age 48, joined Incyte in June 2005 as Manager, External Reporting
Filing states no arrangements or understandings with other persons tied to the appointment
XBiotech entered into an Executive Employment Agreement with CEO and President John Simard, effective October 1, 2025, replacing his prior employment agreements. The agreement sets a $1,250,000 base salary, an annual base bonus of $4,530,442, and severance of three years of salary and bonus if he retires, leaves due to disability, or is terminated without cause.
Agreement signed October 2, 2025, effective October 1, 2025, superseding all prior employment agreements with Mr. Simard
Base salary of $1,250,000 maintained; annual base bonus of $4,530,442, based on the average annual bonus paid over the past five years and determined each year by the Compensation Committee
Severance of three full calendar years of base salary and base bonus on retirement, disability, or termination without cause, paid in cash within 14 days after the release takes effect
If Mr. Simard retires, he will consult for the company for at least 18 months and continue receiving base salary during that period
Proto Labs said its chief technology officer, Oleg Ryaboy, will leave the company effective November 2, 2025, and that Marc Kermisch will take over as Chief Technology & AI Officer effective October 13, 2025. Ryaboy will receive severance benefits under the company's standard executive severance agreement, and the filing does not state a dollar amount. The change is a senior executive transition with no financial results or guidance included.
Oleg Ryaboy, Chief Technology Officer, departs effective November 2, 2025 and is no longer an executive officer as of October 3, 2025
Marc Kermisch appointed Chief Technology & AI Officer effective October 13, 2025
Kermisch previously served as CTO at Emergent Software and as Global Chief Digital and Information Officer at Case New Holland
Ryaboy's severance follows Section 5(A) of the executive severance agreement filed June 6, 2022
Avantor's board elected Gregory Lucier, Executive Chairman and CEO of Corza Medical, as a director effective October 3, 2025, with his term running until the 2026 Annual Meeting of Stockholders. The filing describes this as a board addition with standard non-employee director compensation, and it reports no financial results.
Gregory Lucier elected to the board on October 1, 2025, effective October 3, 2025
Annual cash retainer of $95,000, prorated for 2025, plus restricted stock units valued at $210,000 at grant
Restricted stock units vest in full one year from grant date, subject to continued board service
Board determined Lucier meets New York Stock Exchange independence standards
Pitney Bowes said independent director and Chair Milena Alberti-Perez resigned from the Board effective immediately, on September 29, 2025, and that the resignation was not due to any dispute with the Company. The Board elected Brent Rosenthal as its new independent Chair, effective immediately. The filing describes a change in board leadership, with no financial results or guidance included.
Milena Alberti-Perez resigned from the Board on September 29, 2025, effective immediately, and the company states no disagreement led to the resignation.
Brent Rosenthal was elected independent Chair of the Board, effective immediately, per the October 3, 2025 press release.
Alberti-Perez said she stepped down to focus on new opportunities in the media sector and adjacent industries.
The filing includes no financial results, guidance or dollar figures.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.